Source-grounded facts extracted from REGENEREX PHARMA, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Kenneth W. Perry departed as Chief Financial Officer at REGENEREX PHARMA, INC..
“As of June 5, 2026, the Company has commenced legal proceedings against its former Chief Financial Officer, Kenneth W. Perry (the "Former CFO"), in the matter of Regenerex Pharma, Inc. v. Kenneth W. Perry , Smith County Chancery Court, Case No. 2026-CV-8813.”
Don E. Ray was appointed as Interim Chief Financial Officer at REGENEREX PHARMA, INC..
“In connection with the foregoing, on April 1, 2026, the Board appointed Don E. Ray to serve as Interim Chief Financial Officer of the Company.”
Kenneth Perry was terminated as Chief Financial Officer at REGENEREX PHARMA, INC..
“Following the Committee’s review and recommendation, the Independent Board of Directors approved the termination of Mr. Perry’s employment for Cause, with notice of such termination delivered on May 2, 2026.”
REGENEREX PHARMA, INC.: Changed fiscal year end from March 31 to December 31 (effective 2025-09-22).
“the Board of Directors (the “Board”) of Regenerex Pharma, Inc. (the “Company”) approved a change to the Company’s fiscal year end from March 31 to December 31”
Brent Wilson resigned as Chief Financial Officer at REGENEREX PHARMA, INC..
“Effective March 31, 2025, Mr. Brent Wilson resigned his position as Chief Financial Officer of the Company due to personal reasons.”
Kenneth W. Perry was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..
“Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company”
Deborah L. Pilant was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..
“Effective August 25, 2022, Deborah L. Pilant has been appointed to serve as Chief Financial Officer of the Company.”
Dr. Lee Ori was appointed as Director at REGENEREX PHARMA, INC..
“Effective August 25, 2022, Dr Lee Ori has been elected/appointed to the Board of Directors of the Company.”
Byron Striloff resigned as other_named_officer at REGENEREX PHARMA, INC..
“Effective August 25, 2022, Byron Striloff tendered his letter of resignation to the Company resigning from his position as an Officer of the Company.”
Bruce Sellars resigned as Director at REGENEREX PHARMA, INC..
“Effective August 25, 2022, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as a member of the Board of Directors.”
Irene Getty resigned as Chief Financial Officer at REGENEREX PHARMA, INC..
“Effective August 25, 2022, Irene Getty tendered her letter of resignation to the Company resigning from her positions as Chief Financial Officer”
Lee Ori was appointed as Chief R & D Officer at REGENEREX PHARMA, INC..
“He is replacing Dr. Lee Ori who has been appointed as Chief R & D Officer of the Company for the coming year.”
Troy Thuet was appointed as Chief Operating Officer at REGENEREX PHARMA, INC..
“Effective January 14, 2022, Mr. Troy Thuet has been appointed to serve as Chief Operating Officer of the Company for the coming year.”
Dr. Lee Ori was appointed as Chief Operating Officer at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Dr. Lee Ori has been appointed to serve as Chief Operating Officer of the Company for the coming year.”
Deborah L. Pilant was appointed as Secretary/Treasurer at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Ms. Deborah L. Pilant has been appointed to serve as Secretary/Treasurer of the Company for the coming year.”
Gregory P. Pilant was appointed as Chief Executive Officer and Chairman of the Board at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Mr. Gregory P. Pilant has been appointed to serve as Chief Executive Officer and Chairman of the Board for the Company for the coming year.”
Irene Getty resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.”
Dennis Cox resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.”
Byron Striloff resigned as President at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Byron Striloff tendered his letter of resignation to the Company resigning from his position as President of the Company.”
Bruce Sellars resigned as Chief Executive Officer at REGENEREX PHARMA, INC..
“Effective November 16, 2021, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as Chief Executive Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.